- Home
- EXE vs DGX Comparison
EXE vs DGX Comparison
Compare EXE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXE
- DGX
- Stock Information
- Founded
- EXE 1989
- DGX 1967
- Country
- EXE United States
- DGX United States
- Employees
- EXE N/A
- DGX N/A
- Industry
- EXE
- DGX Medical Specialities
- Sector
- EXE
- DGX Health Care
- Exchange
- EXE NYSE
- DGX Nasdaq
- Market Cap
- EXE 22.8B
- DGX 17.5B
- IPO Year
- EXE 1993
- DGX 1996
- Fundamental
- Price
- EXE $101.22
- DGX $150.96
- Analyst Decision
- EXE Strong Buy
- DGX Buy
- Analyst Count
- EXE 5
- DGX 14
- Target Price
- EXE $113.60
- DGX $168.14
- AVG Volume (30 Days)
- EXE 2.2M
- DGX 741.2K
- Earning Date
- EXE 02-07-2025
- DGX 01-30-2025
- Dividend Yield
- EXE 2.27%
- DGX 1.98%
- EPS Growth
- EXE N/A
- DGX 11.56
- EPS
- EXE 1.89
- DGX 7.44
- Revenue
- EXE $3,291,000,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- EXE N/A
- DGX $7.33
- Revenue Next Year
- EXE N/A
- DGX $8.60
- P/E Ratio
- EXE $53.51
- DGX $20.30
- Revenue Growth
- EXE N/A
- DGX 2.60
- 52 Week Low
- EXE $69.12
- DGX $123.04
- 52 Week High
- EXE $101.46
- DGX $165.32
- Technical
- Relative Strength Index (RSI)
- EXE N/A
- DGX 36.52
- Support Level
- EXE N/A
- DGX $150.28
- Resistance Level
- EXE N/A
- DGX $152.48
- Average True Range (ATR)
- EXE 0.00
- DGX 2.59
- MACD
- EXE 0.00
- DGX -0.35
- Stochastic Oscillator
- EXE 0.00
- DGX 19.98
About EXE EXPAND ENERGY CORPORATION
Expand Energy Corp independent natural gas producer in the United States. It is fueling a more affordable, reliable, and lower-carbon future. The group focused on developing abundant natural gas, oil, and gas liquids to expand energy access.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.